These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The uses of the intensive design in psychopharmacology. Kellner R; Rifkin A; Rada RI Psychopharmacol Bull; 1979 Jul; 15(3):35-7. PubMed ID: 493458 [No Abstract] [Full Text] [Related]
4. [Sensible use of placebo in psychopharmacological research]. Kotler M; Witztum E Harefuah; 1999 May; 136(9):692-4. PubMed ID: 10955091 [No Abstract] [Full Text] [Related]
6. Annual meeting of the New Clinical Drug Evaluation Units (NCDEU) program, Psychopharmacology Research Branch, National Institute of Mental Health, 23-25 May 1978, Key Biscayne, Florida. Psychopharmacol Bull; 1979 Jul; 15(3):22-44. PubMed ID: 493456 [No Abstract] [Full Text] [Related]
7. The application of the principles of clinical drug development to a pharmacological challenge test of the serotonergic system. Pinder RM J Psychopharmacol; 2004 Mar; 18(1):17; author reply 18-9. PubMed ID: 15107179 [No Abstract] [Full Text] [Related]
9. The crossover experiment for clinical trials. Brown BW Biometrics; 1980 Mar; 36(1):69-79. PubMed ID: 7370374 [TBL] [Abstract][Full Text] [Related]
10. The application of good clinical practice to challenge tests. Bailey JE J Psychopharmacol; 2004 Mar; 18(1):16; author reply 18-9. PubMed ID: 15107178 [No Abstract] [Full Text] [Related]
11. [Progress in psychopharmacological researh by video-techniques (VTR) (author's transl)]. Renfordt E Pharmakopsychiatr Neuropsychopharmakol; 1978 Nov; 11(6):266-84. PubMed ID: 740716 [No Abstract] [Full Text] [Related]
12. Analysis of two-period crossover design in a multicenter clinical trial. Castellana JV; Patel HI Biometrics; 1985 Dec; 41(4):969-77. PubMed ID: 3830261 [TBL] [Abstract][Full Text] [Related]
13. Angina clinical trial methodology. Ford I Postgrad Med J; 1991; 67 Suppl 3():S2-8. PubMed ID: 1758828 [TBL] [Abstract][Full Text] [Related]
14. Three-period crossover designs for two treatments. Ebbutt AF Biometrics; 1984 Mar; 40(1):219-24. PubMed ID: 6733230 [TBL] [Abstract][Full Text] [Related]
15. Using the maximum test statistic in the two-period crossover clinical trial. Willan AR Biometrics; 1988 Mar; 44(1):211-8. PubMed ID: 3358989 [TBL] [Abstract][Full Text] [Related]
16. Reading reports of clinical trial results. Kane JM J Clin Psychiatry; 2005 May; 66(5):653. PubMed ID: 15889955 [No Abstract] [Full Text] [Related]
17. [Methodical problems of clinical-psychopharmacological research presented using the example of antidepressive agents]. Bente D Arzneimittelforschung; 1969 May; 19(5):806-8. PubMed ID: 4895502 [No Abstract] [Full Text] [Related]
18. [Voluntary description of drug effects as a method in clinical trials. Presented using the example of pentobarbital, promazine and their combination]. Kohnen R; Lienert GA Arzneimittelforschung; 1979; 29(3):579-84. PubMed ID: 582749 [TBL] [Abstract][Full Text] [Related]
19. Design and conduct issues in surgical clinical trials. Neumayer L Am J Surg; 2004 Dec; 188(6A Suppl):17S-21S. PubMed ID: 15610888 [TBL] [Abstract][Full Text] [Related]
20. Clinical psychopharmacological research in Czechoslovakia. Vinar O Psychopharmacol Bull; 1969 Oct; 5(4):14-21. PubMed ID: 4905337 [No Abstract] [Full Text] [Related] [Next] [New Search]